Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationJan P. Vandenbroucke|PLoS Medicine|2007Cited by 8.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationJan P. Vandenbroucke, R M Bertina, E Briët et al.|The Lancet|1994Cited by 1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisMartin den Heijer, Frits R. Rosendaal, Jan P. Vandenbroucke et al.|New England Journal of Medicine|1996Cited by 1.1k
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyAstrid van Hylckama Vlieg, Frits R. Rosendaal, Jan P. Vandenbroucke et al.|BMJ|2009Cited by 664
Oral Contraceptives and the Risk of Venous ThrombosisJan P. Vandenbroucke, Frits R. Rosendaal, Jan Rosing et al.|New England Journal of Medicine|2001Cited by 590